Bruce Robertson

W.R. Grace & Co. engages in the production and sale of chemicals and materials. It operates through the Grace Catalysts Technologies and Grace Materials Technologies segments. The Grace Catalysts Technologies segment includes catalysts and related products and technologies used in refining, petrochemical and other chemical manufacturing applications. The Grace Materials Technologies segment consists of specialty materials, including silica-based and silica-alumina-based materials, used in coatings, consumer, industrial, and pharmaceutical applications. The firm specializes in chemical processing, coatings and inks, food and beverage, general industrial, nutraceutical, personal care, pharma, and plastics industries. The company was founded by William Russell Grace in 1854 and is headquartered in Columbia, MD.

Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL.

Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA.

Apollo Endosurgery, Inc. provides medical devices for treatment of obesity. It offers OverStitch, an endoscopic suturing system that enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope; and LAP-BAND, an adjustable gastric banding system for weight loss goals. The company was founded by Sergey Kantsevoy, Anthony Kalloo, Robert Hawes, Christopher J. Gostout and Dennis L. McWilliams in 2006 and is headquartered in Austin, TX.

Intersection Medical, Inc. developed cardiovascular monitoring system for patients with congestive heart failure. The company was founded in July 2006 by Scott M. Chetham and was headquartered in Carlsbad, CA.

Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA.

Cerephex Corp. develops and provides therapies and diagnostic technologies for chronic centralized pain. It offers NeuroPoint, a point-of-care medical device that is built upon patented reduced impedance noninvasive cortical electrostimulation signal technology platform developed to unable use by physician-supervised staff in existing clinical outpatient offices. The company was founded by Jeffrey Hargrove and Robert M. Ford on September 26, 2012 and is headquartered in Los Altos, CA.